Does sympathetic modulation by levodopa reduce vascular risk factors in Parkinson disease?
Levodopa use in parkinsonian patients is associated with reduced vascular risk factors. In causal terms this finding might be attributed to the inhibitory action of levodopa-derived dopamine on the sympathetic nervous system.
In this first attempt, it was revealed that CMs express the same conservative attitudes as the general population.